Technological advancement in the global peripheral vascular disease market has led to development of technologies such as novel ‘3D’ stent system, specialty stent for PAD and advent of bioresorbable stent. The report “Global Peripheral Vascular Disease Market – Focus on Technology (Stent, Drug-Coated Balloon, Atherectomy devices, Drug Eluting Stent (DES), PTA Balloon Catheter) Market Outlook 2022” provides an in-depth analysis of global peripheral vascular diseases market overall as well as major technologies such as Peripheral Vascular Stent, Drug-Coated Balloon (DCB), Atherectomy devices, Drug Eluting Stent (DES), PTA Balloon Catheter. Market outlook for overall market as well as aforementioned sub-segments has been provided for the period 2017-22.
The report provides comprehensive coverage on major industry drivers, restraints, and their impact on market growth during the forecast period. Furthermore, the study encompasses various market specific growth opportunities in global peripheral vascular diseases market. The report has been segmented as following:-
Market Segmentation - Technology
• Peripheral Vascular Stent
• Drug-Coated Balloon (DCB)
• Atherectomy devices
• Drug Eluting Stent (DES)
• PTA Balloon Catheter
Country Coverage
• The US
• Japan
• China
Companies Coverage
• Boston Scientific
• Medtronic plc
• Abbott Laboratories
• C.R. Bard
Peripheral vascular disease (PVD) is a circulatory system disorder outside of the brain and heart. It causes blood vessels (arteries and veins) to narrow down, causing blockage or spasm. The condition is referred to as coronary artery disease when narrowing of vessels occurs in the heart; and cerebrovascular disease in the case of brain. It mainly causes pain and fatigue especially in legs. PVD are mainly of two main types - functional and organic PVD. Functional PVD is associated with widening and narrowing of blood vessels in response to external stimuli, without physically damaging blood vessel’s structure. Organic PVD is caused by change in structure of blood vessels.
Treatment of peripheral vascular disease involves use of peripheral vascular devices for undergoing numerous procedures such as vascular stenting, atherectomy, chronic total occlusion repair, transcatheter embolization and vena cava filter implantation. Variety of medical devices are used for each procedure in multiple locations in the hospital. Global PVD market is driven by growth in incidence of peripheral vascular disease, increasing geriatric population, high restenosis rate and rising public awareness of PVD treatment. Around one-fourth of the world's population is possibly inflicted by peripheral artery disease itself. However, certain factors such as stringent regulatory compliance and high costs of treatment have emerged as major hurdles of the industry.
The report “Global Peripheral Vascular Disease Market – Focus on Technology (Stent, Drug-Coated Balloon, Atherectomy devices, Drug Eluting Stent (DES), PTA Balloon Catheter) Market Outlook 2022” provides information on the current scenario, detailed market outlook of the global peripheral vascular disease market with detailed analysis of major technologies such as Stent, Drug-Coated Balloon (DCB), Atherectomy devices, Drug Eluting Stent (DES), PTA Balloon Catheter. Future forecasts of global PVD market overall and across various sub-segments till 2022 is provided in the report. Country analysis of leading peripheral vascular disease devices market such as the US, China and Japan has been covered in the report. Furthermore, major industry players have been prudently analysed in the competitive landscape section of the report in order to provide key comparative insights.
Major industry players operating in the global PVD market include Boston Scientific, Medtronic plc, Abbott Laboratories, C.R. Bard, among others. These players are profiled herein based on attributes such as business overview, product segments and financial analysis. It also compiles performance comparison of aforementioned companies and other leading companies in the segment based on various parameters in the competitive landscape section. In totality, the report provides detailed market analysis, with relevant forecasted data supported by key market dynamics. This information will be helpful in evaluating opportunities in global peripheral vascular diseases market.
1. Executive Summary
2. Research Methodology
3. Peripheral Vascular Disease
3.1 Overview
3.2 Types of PVD
3.2.1 Functional PVD
3.2.2 Organic PVD
3.4 Diagnosis of PVD
3.5 Treatment of PVD
4. Market Analysis
4.1 Market Sizing (Actual & Forecasted)
4.2 Market Share Analysis
4.2.1 Market Share by Devices
4.2.2 Market Share by Drugs
4.2.3 Market Share by Type of Disease
4.2.4 Market Share by Region
5. Country Analysis
5.1 The US
5.1.1 Market Sizing (Actual & Forecasted)
5.1.2 Market Share by Procedure
5.1.3 Market Share by Device
5.2 China
5.2.1 Market Sizing (Actual & Forecasted)
5.3 Japan
5.3.1 Market Sizing (Actual & Forecasted)
6. Market Segmentation
6.1 Peripheral Vascular Stent
6.1.1 Overview
6.1.2 Market Sizing (Actual & Forecasted)
6.1.3 Market Share by Segment
6.1.4 Market Share by Region
6.2 Drug-Coated Balloon (DCB)
6.2.1 Overview
6.2.2 Market Sizing (Actual & Forecasted)
6.3 Atherectomy Devices
6.3.1 Overview
6.3.2 Market Sizing (Actual & Forecasted)
6.4 Drug Eluting Stent (DES)
6.4.1 Overview
6.4.2 Market Sizing (Actual & Forecasted)
6.5 PTA Balloon Catheter
6.5.1 Overview
6.5.2 Market Sizing (Actual & Forecasted)
7. Pricing Analysis
8. Market Dynamics
8.1 Industry Trends & Development
8.1.1 Precision Vascular Robotics
8.1.2 Advent of Bioresorbable stent
8.1.3 Novel ‘3-D’ Stent System
8.1.4 Specialty Stents for PAD
8.1.5 Other New Technologies
8.2 Growth Drivers
8.2.1 Growing Geriatric Population
8.2.2 High Restenosis Rates
8.2.3 Rising Incidences of PAD
8.2.4 Increasing Public Awareness
8.3 Challenges
8.3.1 Strict Regulatory Compliance
8.3.2 High Cost of Treatment
8.3.3 Others
9. Competitive Landscape
9.1 Product Portfolio
9.1.1 Market Share by Competitors
10. Company Profiles
10.1 Boston Scientific
10.2 Medtronic plc
10.3 Abbott Laboratories
10.4 C.R. Bard
List of Tables
Table 1: Symptoms of PVD
Table 2: Tests for Diagnosis of PVD
Table 3: Global Peripheral Intervention Products Pricing Analysis
Table 4: Peripheral Intervention Devices – Self-expanding Stents Pricing Analysis (US$)
Table 5: Peripheral Intervention Devices – Balloon-expandable Stents Pricing Analysis (US$)
Table 6: Peripheral Intervention Devices – Carotid Stents Pricing Analysis (US$)
Table 7: Peripheral Intervention Devices – Covered Endoprostheses Stents Pricing Analysis (US$)
Table 8: Peripheral Intervention Devices – Drug-eluting Stents Pricing Analysis (US$)
Table 9: Peripheral Intervention Devices – PTA Balloon Catheters Pricing Analysis (US$)
Table 10: Peripheral Intervention Devices – Drug-coated Balloons Pricing Analysis (US$)
Table 11: Global Peripheral Vascular Devices Market Players Competitive Landscape
Table 12: Recent FDA Approvals of Peripheral Vascular Products Landscape by Companies
Table 13: Drug-coated Balloon Dilatation Catheters Products Landscape by Companies
Table 14: Comparison of Atherectomy Devices by Leading Market Players
Table 15: Drug-Coated Balloon (DCB) Under Development by Leading Market Players
List of Figures
Figure 1: Rockville Research – Research Methodology
Figure 2: Global Peripheral Vascular Diseases Breakdown by Risk Factors (2017)
Figure 3: Global Peripheral Vascular Disease Market Size by Value, 2014-22E (US$ Millions)
Figure 4: Peripheral Vascular Disease Annual Mortality Rate (per 100,000 people) by Nations (2016)
Figure 5: Global Peripheral Vascular Diseases Market Share by Devices (2017)
Figure 6: Global Peripheral Vascular Diseases Market Share by Drugs (2017)
Figure 7: Global Peripheral Vascular Diseases Market Share by Devices (2017)
Figure 8: Global Peripheral Artery Disease Market Share by Region (2017)
Figure 9: The US Peripheral Vascular Diseases Market Size by Value, 2014-22E (US$ Millions)
Figure 10: The US Peripheral Vascular Disease Intervention Market Share by Procedure (2017)
Figure 11: The US Peripheral Vascular Disease Intervention Market Share by Device (2017)
Figure 12: China Peripheral Vascular Diseases Market Size by Value, 2016-22E (US$ Millions)
Figure 13: China Peripheral Vascular Diseases Market Size by Volume, 2010-17 (Millions)
Figure 14: Japan Peripheral Vascular Diseases Market Size by Value, 2016-22E (US$ Millions)
Figure 15: Global Peripheral Stent Market Size by Value, 2010-22E (US$ Billions)
Figure 16: Global Peripheral Stent Market Share by Segment, 2014-22 (%)
Figure 17: Global Peripheral Stent Market Share by Region (2017)
Figure 18: Global Drug-Coated Balloon Market Size by Value, 2010-22E (US$ Millions)
Excimer Laser Atherectomy
Orbital Atherectomy
Figure 19: Global Atherectomy Devices Market Size by Value, 2010-22E (US$ Millions)
Figure 20: Global Drug Eluting Stent (DES) Market Size by Value, 2010-22E (US$ Millions)
Figure 21: Global PTA Balloon Catheter Market Size by Value, 2010-22E (US$ Millions)
Figure 22: Global Ageing Population (60 and above), 2010-17 (Millions)
Figure 23: Global Peripheral Vascular Diseases Prevalence by Age Group & Gender (2016)
Figure 24: Global Peripheral Artery Diseases Incidence by Region, 2010-16 (Millions)
Figure 25: Global Peripheral Vascular Diseases Market Share by Competitors (2017)
Figure 26: Global DEB Treatment in Lower Extremity Market Share by Competitors (2017)
Figure 27: Boston Scientific Revenue by Business Segment (FY2017)
Figure 28: Boston Scientific Revenue, FY2012-FY2017 (US$ Billions)
Figure 29: Medtronic plc Revenue by Business Segment (FY2017)
Figure 30: Medtronic plc Revenue, FY2012-FY2017 (US$ Billions)
Figure 31: Abbott Laboratories Revenue by Business Segment (FY2017)
Figure 32: Abbott Laboratories Revenue, FY2012-FY2017 (US$ Billions)
Figure 33: C.R. Bard Revenue by Business Segment (FY2017)
Figure 34: C.R. Bard Revenue, FY2012-FY2017 (US$ Billions)
Boston Scientific, Medtronic plc, Abbott Laboratories, C.R. Bard
*If Applicable.